Simultaneous knockdown of ERK3 and TDP2 (shERK3+siTDP2), as compared to single knockdown, did not significantly further enhance cancer cells’ sensitivity to etoposide, suggesting ERK3 and TDP2 cooperatively regulate the response of cancer cells to top2 inhibitor-induced DNA damage and growth inhibition. The gene discussed is TOP2A; the disease is cancer.